# OnCo record paper-abc-02-gemcitabine-cisplatin-nejm-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-abc-02-gemcitabine-cisplatin-nejm-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-abc-02-gemcitabine-cisplatin-nejm-2010" ;
  schema:name "ABC-02: cisplatin plus gemcitabine versus gemcitabine alone for biliary tract cancer"@en ;
  schema:description "Adding cisplatin to gemcitabine lengthened survival by more than three months in advanced bile duct and gallbladder cancer without extra serious toxicity, establishing the chemotherapy standard for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-abc-02-gemcitabine-cisplatin-nejm-2010/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa0908721>, <https://pubmed.ncbi.nlm.nih.gov/20375404/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa0908721> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Valle J, Wasan H, Palmer DH, et al." ;
  onco:cancers <https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:trials <https://onco.cc/trials/abc-02/> ;
  onco:journals <https://onco.cc/journals/nejm/> .
